⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DXR News
Daxor Corporation Common Stock
Updated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026
accessnewswire.com
CJMB
DHX
DXR
ELWT
FLNT
GSIT
NTWK
OMEX
SKYX
LODE
BCHT
CITR
Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress
globenewswire.com
DXR
Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026
globenewswire.com
DXR
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
globenewswire.com
DXR
Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share
globenewswire.com
DXR
Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee
globenewswire.com
DXR
Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business
globenewswire.com
DXR
Daxor Corporation Announces $9 Million Registered Direct Offering
globenewswire.com
DXR
Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer
globenewswire.com
DXR
Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25
globenewswire.com
DXR